<description>&lt;p&gt;Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.1285?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Oncology Author Interviews

JAMA Network

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

MAY 29, 202518 MIN
JAMA Oncology Author Interviews

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

MAY 29, 202518 MIN

Description

Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: